Marshall Wace’s Day One Biopharmaceuticals DAWN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-887,177
| Closed | -$7.04M | – | 2633 |
|
|
2025
Q1 | $7.04M | Sell |
887,177
-210,585
| -19% | -$1.67M | 0.01% | 842 |
|
|
2024
Q4 | $13.9M | Buy |
+1,097,762
| New | +$13.9M | 0.02% | 621 |
|
|
2024
Q3 | – | Sell |
-161,129
| Closed | -$2.22M | – | 2382 |
|
|
2024
Q2 | $2.22M | Buy |
161,129
+26,958
| +20% | +$371K | ﹤0.01% | 1199 |
|
|
2024
Q1 | $2.22M | Buy |
134,171
+16,277
| +14% | +$269K | ﹤0.01% | 1155 |
|
|
2023
Q4 | $1.72M | Sell |
117,894
-343,941
| -74% | -$5.02M | ﹤0.01% | 1064 |
|
|
2023
Q3 | $5.67M | Sell |
461,835
-327,797
| -42% | -$4.02M | 0.01% | 748 |
|
|
2023
Q2 | $9.43M | Buy |
+789,632
| New | +$9.43M | 0.02% | 659 |
|
|
2022
Q3 | – | Sell |
-145,898
| Closed | -$2.61M | – | 2649 |
|
|
2022
Q2 | $2.61M | Buy |
145,898
+128,155
| +722% | +$2.29M | 0.01% | 1477 |
|
|
2022
Q1 | $176K | Buy |
+17,743
| New | +$176K | ﹤0.01% | 2412 |
|